Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy
Authors
Keywords
Locoregional recurrence, Distant metastasis, Pathologic N1, Non-small cell lung cancer, Extra capsular extension, Lymph node ratio
Journal
Radiologia Medica
Volume 121, Issue 9, Pages 696-703
Publisher
Springer Nature
Online
2016-05-26
DOI
10.1007/s11547-016-0648-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracapsular Extension of Pelvic Lymph Node Metastasis is an Independent Prognostic Factor in Bladder Cancer: A Systematic Review and Meta-analysis
- (2015) Tae Sik Ahn et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic impact of lymph node metastasis in distal cholangiocarcinoma
- (2015) M. Kiriyama et al. BRITISH JOURNAL OF SURGERY
- Nodal Stage of Surgically Resected Non-Small Cell Lung Cancer and Its Effect on Recurrence Patterns and Overall Survival
- (2015) John M. Varlotto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Recursive Partitioning Analysis of Lymph Node Ratio in Breast Cancer Patients
- (2015) Yao-Jen Chang et al. MEDICINE
- Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer
- (2015) Han-xiang Zhan et al. World Journal of Surgical Oncology
- Prognostic Factors in Operated Stage IIIC, Pathological N3a Breast Cancer Patients
- (2014) Ibrahim Turker et al. Breast Care
- Prognostic significance of lymph node ratio in esophageal cancer
- (2014) Nana Wang et al. TUMOR BIOLOGY
- Prognostic Significance of the Extent of Lymph Node Involvement in Stage II-N1 Non-small Cell Lung Cancer
- (2013) Zi-Ming Li et al. CHEST
- Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Cancer
- (2013) Damien Urban et al. Journal of Thoracic Oncology
- Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy
- (2013) Chengcheng Fan et al. Radiation Oncology
- Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis
- (2013) Charlotte Billiet et al. RADIOTHERAPY AND ONCOLOGY
- Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer
- (2011) Sirisha Jonnalagadda et al. CANCER
- Local Failure in Resected N1 Lung Cancer: Implications for Adjuvant Therapy
- (2011) Kristin A. Higgins et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy
- (2010) Lucyna Kepka et al. RADIOTHERAPY AND ONCOLOGY
- Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer
- (2010) J. P. Wisnivesky et al. THORAX
- Impact of Postoperative Radiation Therapy on Survival in Patients With Complete Resection and Stage I, II, or IIIA Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial
- (2008) Jean-Yves Douillard et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started